Cardiff Oncology Inc Forecast, price target & analysts
Cardiff Oncology Inc Target price 2026 - Analyst rating & recommendation
Cardiff Oncology Inc Classifications & Recommendation
Cardiff Oncology Inc Price Target
| Target Price | $6.12 |
| Price | $1.28 |
| Potential |
378.13%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Cardiff Oncology Inc 2027 .
The average Cardiff Oncology Inc target price is $6.12.
This is
378.13%
register free of charge
$12.60
884.38%
register free of charge
$2.02
57.81%
register free of charge
|
|
| A rating was issued by 12 analysts: 7 Analysts recommend Cardiff Oncology Inc to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Cardiff Oncology Inc stock has an average upside potential 2027 of
378.13%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.59 | 0.34 |
| 13.24% | 43.00% | |
| Net Margin | -7,776.27% | -13,296.53% |
| 16.32% | 70.99% |
9 Analysts have issued a sales forecast Cardiff Oncology Inc 2026 . The average Cardiff Oncology Inc sales estimate is
This results in the following potential growth metrics:
10 Cardiff Oncology Inc Analysts have issued a net profit forecast 2026. The average Cardiff Oncology Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.69 | -0.65 |
| 27.37% | 5.80% | |
| P/E | negative | |
| EV/Sales | 200.38 |
10 Analysts have issued a Cardiff Oncology Inc forecast for earnings per share. The average Cardiff Oncology Inc EPS is
This results in the following potential growth metrics and future valuations:
Cardiff Oncology Inc...
Current Cardiff Oncology Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 15 2026 |
| William Blair |
Locked
➜
Locked
|
Locked | Aug 12 2026 |
| Craig-Hallum |
Locked
➜
Locked
|
Locked | Jun 03 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 01 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Jun 01 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 25 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 28 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 15 2026 |
|
Locked
William Blair:
Locked
➜
Locked
|
Aug 12 2026 |
|
Locked
Craig-Hallum:
Locked
➜
Locked
|
Jun 03 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 01 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Jun 01 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 25 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 28 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
